11.43
0.55 (5.06%)
| Penutupan Terdahulu | 10.88 |
| Buka | 10.88 |
| Jumlah Dagangan | 8,614,637 |
| Purata Dagangan (3B) | 8,955,533 |
| Modal Pasaran | 24,988,477,440 |
| Harga / Jualan (P/S) | 3.84 |
| Harga / Buku (P/B) | 0.720 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 15 Mar 2026 |
| Margin Keuntungan | 498.23% |
| Margin Operasi (TTM) | 1.56% |
| EPS Cair (TTM) | -0.640 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 43.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.74% |
| Nisbah Semasa (MRQ) | 2.72 |
| Aliran Tunai Operasi (OCF TTM) | 75.65 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -48.48 M |
| Pulangan Atas Aset (ROA TTM) | 0.13% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.46% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | GENSCRIPT BIO | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.38 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| GENSCRIPT BIO | 25 B | - | - | 0.720 |
| CARSGEN-B | 8 B | - | - | 6.98 |
| LEPU BIO-B | 8 B | - | - | 10.02 |
| OCUMENSION-B | 6 B | - | - | 1.32 |
| JACOBIO-B | 5 B | - | - | 5.53 |
| BIODLINK-B | 3 B | - | 211.50 | 3.52 |
|
Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 36.90% |
| % Dimiliki oleh Institusi | 20.86% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |